Folliculosebaceous-apocrine hamartoma

From WikiMD's WELLNESSPEDIA


Folliculosebaceous-apocrine hamartoma
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Skin lesion
Complications N/A
Onset
Duration
Types N/A
Causes
Risks
Diagnosis Histopathology
Differential diagnosis Nevus sebaceus, Trichofolliculoma, Sebaceous hyperplasia
Prevention N/A
Treatment
Medication
Prognosis
Frequency
Deaths N/A


Folliculosebaceous-apocrine hamartoma is a rare, benign skin lesion that is characterized by an overgrowth of the hair follicle, sebaceous gland, and apocrine gland. It is considered a type of hamartoma, which is a benign tumor-like mass composed of an overgrowth of mature cells and tissues normally present in the affected part, but often arranged in an abnormal way.

Clinical Presentation[edit]

Folliculosebaceous-apocrine hamartoma typically presents as a solitary, small, skin-colored or slightly pigmented papule or nodule. It is usually located on the face or scalp, but can also occur on the trunk or extremities. The lesion is usually asymptomatic, but it can sometimes cause pain or discomfort.

Diagnosis[edit]

The diagnosis of folliculosebaceous-apocrine hamartoma is usually made based on the clinical presentation and histopathological examination of the lesion. The histopathological features include an overgrowth of the hair follicle, sebaceous gland, and apocrine gland, with the presence of dilated follicular and sebaceous ducts and cystic spaces filled with keratinous material.

Treatment[edit]

The treatment of folliculosebaceous-apocrine hamartoma is usually surgical excision of the lesion. This is usually curative, as the lesion is benign and does not have malignant potential. However, recurrence can occur if the lesion is not completely excised.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.